Mentor carries out final tests for Botox alternative
Mentor Corporation says it has begun a Phase 2 dose-finding study for its botulinum toxin type A product focused on cosmetic indications in the US - a move that aims to tap into the still growing market for non-surgical anti-aging cosmetic procedures.